DETAILED ACTION
Notice of Pre-AIA or AIA Status
1. The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA .
Election/Restrictions
2. Applicant’s election without traverse of Group I, and species shown below, in the reply filed on December 19, 2025 is acknowledged.
PNG
media_image1.png
580
592
media_image1.png
Greyscale
PNG
media_image2.png
394
448
media_image2.png
Greyscale
3. Examination followed guidelines provided by MPEP 803.02. The elected species appeared to be novel and nonobvious over the prior art. Therefore, the search and examination was extended. Prior art was found that anticipates the claims with respect to a nonelected species. The Markush claims were rejected and claims to nonelected species were withdrawn from further consideration. The claims were searched to the extent of the elected species, the full scope of claims 7, 8 and 10-12 and additionally to the nonelected species shown below.
4. Claims 5 and 13-20 withdrawn from further consideration pursuant to 37 CFR 1.142(b) as being drawn to a nonelected subject matter. Election was made without traverse in the reply filed on December 19, 2025.
Status of Claims
5. Claims 1 and 3-20 are pending. Claims 1, 3, 4 and 6-12 encompass the elected species and are within the elected Group I. Claim 1 is independent. Claims 5 and 13-20 are withdrawn.
Priority
6. Receipt is acknowledged of certified copies of papers required by 37 CFR 1.55.
Information Disclosure Statement
7. The information disclosure statements (dated June 27, 2024 and May 7, 2024 and June 1, 2023) were in compliance with the provisions of 37 CFR 1.97 and 37 CFR 1.98. The statements were considered. Signed copies of form 1449 are enclosed herewith.
Claim Objections
8. Claims 7, 8 and 10-12 objected to as being dependent upon a rejected base claim, but would be allowable if rewritten in independent form including all of the limitations of the base claim and any intervening claims.
Claim Rejections - 35 USC § 102
The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action:
A person shall be entitled to a patent unless –
(a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention.
9. Claim(s) 1, 3, 4, 6 and 9 is/are rejected under 35 U.S.C. 102(a)(1) as being anticipated by Fleming et al. as evidenced by Deuterium-Wikipedia. The reference has a publication date of 1974 which antedates the present claims having an effective filing date of January 21, 2022 and priority claim to foreign application dated January 22, 2021.
The reference teaches the following reaction:
PNG
media_image3.png
404
352
media_image3.png
Greyscale
PNG
media_image4.png
194
358
media_image4.png
Greyscale
PNG
media_image5.png
22
289
media_image5.png
Greyscale
Therefore, the reference teaches the preparation of a deuterated anthracene compound Chemical Formula 2 wherein Ar1=D (natural abundance including all isotopes having b = 1-8) – Claim 4, by reacting a halogenated benzene having at least one deuterium (natural abundance) at various positions including d5. Ar2=H/D (natural abundance). Claims 1, 3 The reference teaches using a halogen supplying agent (compound 13) to prepared the compound of formula (5) before the synthesizing of the deuterated anthracene compound. Claim 6. The reference teaches the synthesizing of Chemical Formula 2 (anthracene compound) using a solution comprising halogenated benzene-d5 (natural abundance) which is compound 13, the compound of Chemical formula 1 (corresponds to 4 in the prior art), 2,2,6,6-tetramethylpiperidine (compound 15 in the prior art reference), an alkyllithium (BuLi in the prior art), and an ether based solvent (THF). Claim 9. It is noted that deuterium exists in natural abundance as evidenced by Deuterium – Wikipedia. Therefore, the limitations of claims 1, 3,4, 6 and 9 are met by Fleming et al.
Conclusion
Any inquiry concerning this communication or earlier communications from the examiner should be directed to SUN JAE YOO whose telephone number is (571)272-9074. The examiner can normally be reached Mon-Fri 8-5.
Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice.
Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000.
/SUN JAE YOO/Primary Examiner, Art Unit 1621